Physician profile
James Bates
NPI 1174692206
$47,444.09
in general payments reported to CMS, 2019-2025
35 companies · $1,362 in 2025
The $1,362 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $19K · 2021: $228 · 2022: $94.67 · 2023: $609 · 2024: $291 · 2025: $1,362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747 · Travel and Lodging: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.28 |
| Travel and Lodging | $514.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omnilife Science, INC | $43,554.49 | 2019-2020 | |
| Medacta USA, INC. | $1,026.21 | 2024-2025 | Gmk Sphere |
| Sportstek Medical, INC | $794.00 | 2019 | |
| Maxx Orthopedics, INC. | $331.88 | 2023 | |
| Depuy Synthes Sales INC. | $315.27 | 2019-2025 | Orthovisc, Truespan Orthocord, Healix Knotless Peek |
| Zimmer Biomet Holdings, INC. | $197.46 | 2025 | Arcos |
| Stryker Corporation | $160.56 | 2019-2024 | Gamma |
| Bioventus LLC | $107.02 | 2021-2025 | Durolane, Xcell |
| Davol INC. | $104.91 | 2025 | Arista |
| Exactech, INC. | $93.00 | 2023 | |
| Globus Medical, INC. | $85.80 | 2023 | Clavicular Fracture Fixation, Proximal Humerus Strut |
| Catalyst Orthoscience | $56.91 | 2025 | |
| Pacira Therapeutics, INC. | $50.87 | 2019-2021 | |
| Baudax Bio INC. | $50.32 | 2020 | |
| Encore Medical, Lp | $49.05 | 2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $45.25 | 2021-2022 | |
| Smith+Nephew, INC. | $39.64 | 2021 | |
| Integra Lifesciences Corporation | $35.30 | 2021 | |
| Convatec INC. | $34.67 | 2019-2023 | |
| Nevro Corp. | $32.33 | 2022 | |
| Boston Scientific Corporation | $27.94 | 2020 | |
| Abbvie INC. | $23.87 | 2021 | |
| Glaukos Corporation | $22.47 | 2021 | |
| Acera Surgical, INC. | $21.65 | 2023 | Restrata Wound Matrix |
| Solventum Corporation | $21.56 | 2025 | Prevena |
| Kerecis Limited | $19.38 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $18.99 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.78 | 2022 | |
| Fidia Pharma USA INC. | $17.01 | 2024 | Hyalgan, Hymovis, Triluron |
| Arthrosurface Incorporated | $15.97 | 2020 | |
| Endo Pharmaceuticals INC. | $15.58 | 2019 | |
| Avanos Medical | $15.06 | 2019 | |
| Becton, Dickinson and Company | $14.48 | 2024 | |
| Acumed LLC | $13.37 | 2024 | Acumed |
| Ermi LLC | $13.04 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.